Found: 9
Select item for more details and to access through your institution.
Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 85, doi. 10.1159/000448802
- By:
- Publication type:
- Article
Determination of the Mutant Prevention Concentration and the Mutant Selection Window of Topical Antimicrobial Agents against Propionibacterium acnes.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 94, doi. 10.1159/000449280
- By:
- Publication type:
- Article
Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 100, doi. 10.1159/000449422
- By:
- Publication type:
- Article
In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 105, doi. 10.1159/000449367
- By:
- Publication type:
- Article
Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 111, doi. 10.1159/000448942
- By:
- Publication type:
- Article
Adaptive Cross-Resistance to Aminoglycoside Antibiotics in Pseudomonas aeruginosa Induced by Topical Dosage of Neomycin.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 121, doi. 10.1159/000449368
- By:
- Publication type:
- Article
Biofilm Formation Restrained by Subinhibitory Concentrations of Tigecyclin in Acinetobacter baumannii Is Associated with Downregulation of Efflux Pumps.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 128, doi. 10.1159/000450537
- By:
- Publication type:
- Article
A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 134, doi. 10.1159/000450748
- By:
- Publication type:
- Article
Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20%.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 2, p. 140, doi. 10.1159/000452756
- By:
- Publication type:
- Article